BlackRock’s Q32 Bio QTTB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.51M | Buy |
118,507
+32,360
| +38% | +$270K | ﹤0.01% | 4236 |
|
|
2026
Q1 | $553K | Buy |
86,147
+26,215
| +44% | +$125K | ﹤0.01% | 4503 |
|
|
2025
Q4 | $199K | Sell |
59,932
-33,073
| -36% | -$93.5K | ﹤0.01% | 4724 |
|
|
2025
Q3 | $184K | Sell |
93,005
-85,672
| -48% | -$165K | ﹤0.01% | 4692 |
|
|
2025
Q2 | $266K | Sell |
178,677
-278,694
| -61% | -$475K | ﹤0.01% | 4601 |
|
|
2025
Q1 | $755K | Sell |
457,371
-10,071
| -2% | -$27.1K | ﹤0.01% | 4273 |
|
|
2024
Q4 | $1.61M | Buy |
467,442
+58,783
| +14% | +$1.86M | ﹤0.01% | 4092 |
|
|
2024
Q3 | $18.2M | Buy |
408,659
+66,390
| +19% | +$2.44M | ﹤0.01% | 3100 |
|
|
2024
Q2 | $6.14M | Buy |
342,269
+297,696
| +668% | +$7.12M | ﹤0.01% | 3614 |
|
|
2024
Q1 | $760K | Sell |
44,573
-15,989
| -26% | -$220K | ﹤0.01% | 4278 |
|
|
2023
Q4 | $663K | Sell |
60,562
-898
| -1% | -$13.1K | ﹤0.01% | 4359 |
|
|
2023
Q3 | $1.29M | Sell |
61,460
-44
| -0.1% | -$897 | ﹤0.01% | 4157 |
|
|
2023
Q2 | $980K | Sell |
61,504
-5,359
| -8% | -$96.2K | ﹤0.01% | 4299 |
|
|
2023
Q1 | $1.24M | Sell |
66,863
-5,780
| -8% | -$144K | ﹤0.01% | 4258 |
|
|
2022
Q4 | $1.65M | Sell |
72,643
-18,209
| -20% | -$483K | ﹤0.01% | 4214 |
|
|
2022
Q3 | $2.63M | Sell |
90,852
-1,186
| -1% | -$48.4K | ﹤0.01% | 4050 |
|
|
2022
Q2 | $3.26M | Sell |
92,038
-122,959
| -57% | -$4.2M | ﹤0.01% | 4010 |
|
|
2022
Q1 | $11.8M | Buy |
214,997
+15,676
| +8% | +$974K | ﹤0.01% | 3489 |
|
|
2021
Q4 | $13.1M | Buy |
199,321
+6,486
| +3% | +$630K | ﹤0.01% | 3513 |
|
|
2021
Q3 | $27.3M | Buy |
192,835
+6,272
| +3% | +$799K | ﹤0.01% | 3077 |
|
|
2021
Q2 | $24.4M | Buy |
186,563
+27,389
| +17% | +$3.42M | ﹤0.01% | 3179 |
|
|
2021
Q1 | $27M | Buy |
159,174
+5,666
| +4% | +$1.19M | ﹤0.01% | 3018 |
|
|
2020
Q4 | $31.2M | Buy |
153,508
+1,276
| +0.8% | +$247K | ﹤0.01% | 2764 |
|
|
2020
Q3 | $29.3M | Sell |
152,232
-3,872
| -2% | -$868K | ﹤0.01% | 2641 |
|
|
2020
Q2 | $42.7M | Buy |
156,104
+39,065
| +33% | +$10.4M | ﹤0.01% | 2349 |
|
|
2020
Q1 | $32.7M | Sell |
117,039
-2,509
| -2% | -$768K | ﹤0.01% | 2324 |
|
|
2019
Q4 | $44.5M | Buy |
119,548
+646
| +0.5% | +$185K | ﹤0.01% | 2439 |
|
|
2019
Q3 | $38.7M | Buy |
118,902
+3,116
| +3% | +$1.06M | ﹤0.01% | 2439 |
|
|
2019
Q2 | $40.8M | Buy |
115,786
+37,926
| +49% | +$14.9M | ﹤0.01% | 2444 |
|
|
2019
Q1 | $38.9M | Sell |
77,860
-3,276
| -4% | -$1.46M | ﹤0.01% | 2407 |
|
|
2018
Q4 | $32.7M | Buy |
81,136
+46,505
| +134% | +$17.6M | ﹤0.01% | 2463 |
|
|
2018
Q3 | $14.2M | Buy |
34,631
+5,132
| +17% | +$1.74M | ﹤0.01% | 3051 |
|
|
2018
Q2 | $10.8M | Buy |
+29,499
| New | +$10.6M | ﹤0.01% | 3198 |
|
Other funds holding QTTB
O
BCM
AVLSA
BI
RCM
OM
LGM
SC
BlackRock's QTTB Position: Q2 2026 in Review
BlackRock increased its Q32 Bio (QTTB) stake by 38% in Q2 2026, buying an estimated $270K and bringing the position to 118,507 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #4236.
BlackRock first reported a position in QTTB in Q2 2018 and has held it in 33 quarters since. The position peaked at $44.5M in Q4 2019. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.
- BlackRock held 118,507 shares of Q32 Bio worth $1.51M as of Q2 2026.
- BlackRock bought 32,360 Q32 Bio shares in Q2 2026, an estimated $270K.
- Q32 Bio made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4236 holding.
- BlackRock first reported a position in Q32 Bio in Q2 2018 and has held it in 33 quarters since.
- BlackRock's Q32 Bio position peaked at $44.5M in Q4 2019.
- 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.